Unilever is one of the world’s leading suppliers of food, home care, personal care and refreshment products with sales in over 190 countries and reaching 2.5 billion consumers a day. It has 169,000 employees and generated sales of €52.7 billion in 2016. Over half (57%) of the company’s footprint is in developing and emerging markets. Unilever has more than 400 brands found in homes around the world, including Persil, Dove, Knorr, Domestos, Hellmann’s, Lipton, Wall’s, PG Tips, Ben & Jerry’s, Magnum and Lynx.
Unilever’s Sustainable Living Plan commits to helping more than a billion people take action to improve their health and well-being by 2020, halving the environmental impact of our products by 2030, and enhancing the livelihoods of millions of people by 2020.
Gavi and Unilever have entered into a partnership that builds awareness and drives behaviour change among parents by stressing the importance of handwashing with soap and immunisation to tackle the biggest killers of children – pneumonia and diarrhoea.
Unilever invested €2.9 million in December 2016 in a three-year partnership between its Lifebuoy brand – the world’s number one germ protection soap – and Gavi; these funds are matched by the Gavi matching fund. The partnership – Safal Shuruaat, or ‘Successful Beginnings’ – combines Lifebuoy’s marketing and behaviour change interventions on the importance of handwashing with soap, with Gavi’s messaging on the importance of vaccination to deliver joint demand generation.
At Gavi’s Mid Term Review in Abu Dhabi at the end of 2018, an extension of this partnership in India was announced between Unilever and Gavi. Unilever committed an additional €1 million towards the programme, matched again by the Gavi matching fund.
At the Global Vaccine Summit in June 2020, Unilever announced a further €3 million contribution to expand the award-winning ‘Safal Shuruaat/Successful Beginnings’ partnership to an additional country. Gavi will aim to match through the Gavi Matching Fund, bringing the total sum to €6 million. This is in addition to a donation of almost 2.9 million bars of Lux soap to the Pakistan immunisation programme to protect to parents seeking immunisation services and healthcare workers on the frontline.
Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000-2021 and Q1-Q2 2022 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014-2021 and Q1-Q2 2022 where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions (for pledges made prior to the June 2020 donor pledging conference): non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2022 and for years 2023 and beyond are expressed in US$ equivalents using the applicable forecast rates from Bloomberg as at 30 June 2022 or using the rates applicable to any hedge agreement in place.
Future contributions (for pledges at the June 2020 donor pledging conference): non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2022 and for years 2023 and beyond are expressed in US$ equivalents using the spot rates from Bloomberg as at 30 June 2022 or using the rates applicable to any hedge agreement in place.
Received contributions: non-US$ contributions for 2000-2021 and Q1-Q2 2022 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)
Future contributions: non-US$ contributions for Q3-Q4 2022 and for years 2023 and beyond are expressed in US$ equivalents as follows:
- For signed contribution agreements: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements.
- For contribution agreements not yet signed: contributions are expressed in US$ equivalents using the applicable spot rates from Bloomberg as at 30 June 2022.
Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due by the donor in the event that a Gavi-supported programme country is in protracted arrears with the International Monetary Fund. As of 29 June 2021, there is no longer any reduction applied, as all countries from the reference portfolio have cleared their arrears with the IMF.